Skip to main content
Premium Trial:

Request an Annual Quote

Roche Launches $2.2B Debt Tender Offer

NEW YORK (GenomeWeb) – Roche announced late yesterday that it has commenced a $2.2 debt tender offer.

The Swiss pharmaceuticals, diagnostics, and research products giant said that it launched an offer to purchase for cash the 5.25 percent Senior Notes due 2035 issued by its Genentech subsidiary and the 7 percent Senior Notes due 2039 issued by Roche Holdings.

The Genentech Senior Notes have a principal outstanding amount of $500 million, while the Roche Holdings Senior Notes have a principal outstanding amount of $2.5 billion. It listed the Genentech notes as having a higher acceptance priority level.

The offer is set to expire on Nov. 26, 2014, unless Roche terminates or extends the offer before that time.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.